Navigation Links
NIH funds 10 international centers of excellence for malaria research

In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.

The seven-year awards will establish the International Centers of Excellence for Malaria Research (ICEMRs) in regions where malaria is endemic, including parts of Africa, Asia, the Pacific Islands and Latin America. These regions include some of the focus countries of the President's Malaria Initiative, an effort that since 2005 has worked to fight malaria in the regions most affected by the disease. Infection by malaria-causing parasites results in approximately 240 million cases around the globe annually, and causes more than 850,000 deaths each year. Teams of scientists involved in the ICEMR program will be conducting research in more than 20 countries.

"One of our primary goals with these centers is to fund cutting-edge research in malaria-endemic areas that will keep up with the rapidly changing epidemiology of the disease," says NIAID Director Anthony S. Fauci, M.D.

Malaria has been eliminated from many parts of the globe, but 40 percent of the world's population still live in areas where they are at risk for contracting the disease. According to Lee Hall, M.D., Ph.D., chief of the Parasitology and International Programs Branch in NIAID, sustainable and effective malaria control requires research in multiple settings on the complex interactions among the parasite, the mosquito vector, the local ecology and the human host.

"The ICEMR program seeks to address this need by creating a network of multidisciplinary research centers in malaria-endemic settings," Dr. Hall says. "The centers aim to generate critical knowledge, tools and evidence-based strategies to support intervention and control programs by government organizations and health care institutions."

The centers will integrate clinical and field approaches with laboratory-based immunologic, molecular and genomic methods. They will adapt their research to changes in malaria epidemiology and emerging research needs as well as opportunities within the specific regions. Their findings are expected to help inform how new interventions and control strategies are designed and evaluated in the future.

Each center will

  • Design and conduct multidisciplinary research on the epidemiology, transmission and pathogenesis of malaria in endemic geographic regions
  • Design and conduct special projects to capitalize on new opportunities and emerging public health needs
  • Develop and conduct training and career development programs for researchers from malaria-endemic areas

Overall, these centers are expected to bring critical infrastructure to these endemic regions and help build training and research capacity to combat malaria worldwide.

The principal investigators selected to establish the ICEMRs are as follows:

  • Malaria Transmission and the Impact of Control Efforts in Southern Africa
    Principal Investigator: Peter Agre, M.D.
    Lead Institution: Johns Hopkins University, Baltimore

  • Center for the Study of Complex Malaria in India
    Principal Investigator: Jane Carlton, Ph. D.
    Lead Institution: New York University School of Medicine, New York City

  • Southeast Asia Malaria Research Center
    Principal Investigator: Liwang Cui, Ph.D.
    Lead Institution: Pennsylvania State University, University Park

  • Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda
    Principal Investigator: Matthew Dorsey, M.D.
    Lead Institution: University of California, San Francisco

  • Latin American Center for Malaria Research and Control
    Principal Investigator: Socrates Herrera-Valencia, M.D.
    Lead Institution: Caucaseo Scientific Research Center, Cali, Colombia

  • Research to Control and Eliminate Malaria in SE Asia and SW Pacific
    Principal Investigator: James Kazura, M.D.
    Lead Institution: Case Western Reserve University, Cleveland

  • Population-based Approach to Malaria Research and Control in West Africa
    Principal Investigator: Donald Krogstad, M.D.
    Lead Institution: Tulane University, New Orleans

  • Malaria Evolution in South Asia
    Principal Investigator: Pradipsinh Rathod, Ph. D.
    Lead Institution: University of Washington, Seattle

  • Determinants of Malaria Disease in Malawi
    Principal Investigator: Terrie Taylor, D.O.
    Lead Institution: Michigan State University, East Lansing

  • Peruvian/Brazilian Amazon Center of Excellence in Malaria
    Principal Investigator: Joseph Vinetz, M.D.
    Lead Institution: University of California, San Diego


Contact: Nalini Padmanabhan
NIH/National Institute of Allergy and Infectious Diseases

Related medicine news :

1. Federal Recovery Funds Allow Eries Shriners Hospital to Reduce Energy Costs, Invest Savings in Patient Care
2. Three Security Firms Create Consortium To Automate Meaningful Use Requirements And Qualify Clients For $Billions In Stimulus Funds
3. Study: Federal funds support health depts., but leadership is key
4. Legacy(SM) Case for Tobacco Funds to be Heard by Ohio Supreme Court
5. Miles for Hope’s Moving Towards A Cure(SM) Brain Tumor Walk in Boston Raising Funds for Brain Tumor Vaccine and Massachusetts General Hospital
6. EVMS receives more than $1 million in federal funds to develop new ways to reverse type 1 diabetes
7. Major League Baseball Players Alumni Help Lazarex Cancer Foundation Raise Funds
8. Prize4Life Launches “Art, Life, Spring” Online Art Auction to Raise Funds for Lou Gehrig's Disease Research
9. Just Graduated College Seniors Ride for Loved Ones With Diabetes Cycling Cross Country to Raise Funds to Help Find a Cure
10. Only 5 percent of cancer research funds are spent on metastases, yet it kills 90 percent of all cancer patients
11. Amazing Grace Charity Golf Tournament to Raise Awareness, Funds for Neuroblastoma
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... November 27, 2015 , ... An ... way to dispense prescription medications at home, so he invented the patent-pending ELECTRONIC ... and dispense prescription medications. In doing so, it could help to prevent potential ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a ... component is distributed nationally, through a vast social media strategy and across a ...
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent with ... the 2016 Building Better Radiology Marketing Programs meeting will showcase some ... March 6, 2016, at Caesars Palace in Las Vegas with a pre-conference session ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you ... for not only fulfilling the needs of advisers and clients but going above ... and providing top-tier customer service. However, there's always room for improvement, which is ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Países Bajos, November 26, 2015 ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... con la terapia fotodinámica de Bremachlorin para el cáncer ... enfoque combina la inmunoterapia con la terapia fotodinámica de ... Clinical Cancer Research . --> Clinical Cancer ...
(Date:11/26/2015)... 26, 2015 ... aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie voor ... ) --> ... ) Uit ... Centrum (LUMC) blijkt ...
(Date:11/26/2015)... 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ... kidney transplantation is expected to boost the market growth, as ... transplantation. --> 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ...
Breaking Medicine Technology: